Custodia Jimenez-Garcia

Madrid, MD 28922, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

New Insights into Iodide Transport Defects (ITDs) from the Characterization of a Heterozygous NIS Missense Variant (p.G288S) Identified in a Family with Thyroid Dysfunction During Pregnancy.

New Insights into Iodide Transport Defects (ITDs) from the Characterization of a Heterozygous NIS Missense Variant (p.G288S) Identified in a Family with Thyroid Dysfunction During Pregnancy.

Journal: International journal of molecular sciences

Published: March 24, 2026

Targeted radioiodine therapy of ovarian cancer via the sodium/iodide symporter (NIS).

Targeted radioiodine therapy of ovarian cancer via the sodium/iodide symporter (NIS).

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 15, 2025

Metabolic buffering restricts phenotype switching in melanoma.

Metabolic buffering restricts phenotype switching in melanoma.

Journal: The EMBO journal

Published: May 28, 2025

Metabolic buffering suppresses phenotype switching in cancer.

Metabolic buffering suppresses phenotype switching in cancer.

Journal: bioRxiv : the preprint server for biology

Published: April 28, 2025

MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma.

MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma.

Journal: Cell reports

Published: January 10, 2025

Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.

Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.

Journal: bioRxiv : the preprint server for biology

Published: January 07, 2025

Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression.

Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression.

Journal: Genes & development

Published: June 03, 2024

Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.

Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.

Journal: Journal of medicinal chemistry

Published: April 09, 2024

Hyperglycemia-driven signaling bridges between diabetes and cancer.

Hyperglycemia-driven signaling bridges between diabetes and cancer.

Journal: Biochemical pharmacology

Published: March 29, 2024

SIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells.

SIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells.

Journal: International journal of biological sciences

Published: March 02, 2024

Phenotype-specific melanoma uptake of fatty acid from human adipocytes activates AXL and CAV1-dependent β-catenin nuclear accumulation.

Phenotype-specific melanoma uptake of fatty acid from human adipocytes activates AXL and CAV1-dependent β-catenin nuclear accumulation.

Journal: bioRxiv : the preprint server for biology

Published: February 08, 2024

Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.

Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.

Journal: Journal of nanobiotechnology

Published: February 07, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026